Latest Strategy News

RareX Limited has won a $175,000 government-backed drilling grant to advance exploration of significant gallium mineralisation at its Khaleesi Project in Western Australia, underpinning the project’s critical minerals promise.

Dimerix has inked an exclusive US licensing agreement with Amicus Therapeutics for DMX-200, a promising Phase 3 treatment for FSGS, unlocking $30 million upfront and up to $560 million in milestones.

Australian Strategic Materials (ASM) outlines progress on its Korean Metals Plant ramp-up, strategic plans for a US metals facility, and conditional funding support for the Dubbo Project, reinforcing its mine-to-metals supply chain ambitions.

Baby Bunting Group unveils its ambitious ‘Store of the Future’ strategy, targeting a return to double-digit EBITDA margins through store refurbishments, new small format pilots, and enhanced omni-channel capabilities. The company sets FY25 NPAT guidance between $10 million and $12.5 million, underpinned by a 40% gross margin target.

Pilot Energy confirms regulatory compliance and operational progress at the Head Field, advancing the repurposing of Cliff Oil infrastructure into a carbon storage facility as part of the Mid West Clean Energy Project.

Eureka Group Holdings has upsized its debt facilities to $185 million with improved terms, enhancing its financial flexibility to expand residential developments across Australia.

Legacy Minerals has reported compelling new assay results from historic diamond drilling at its Drake Project in NSW, confirming broad, high-grade gold and base metal mineralisation that supports resource growth and robust economics.

Baby Bunting reports a 2.9% year-to-date comparable store sales growth and opens an innovative new store format in Melbourne, raising its FY25 NPAT guidance amid strong early results.

Hammer Metals has identified promising high-grade gold targets adjacent to the multi-million-ounce Bronzewing mine, setting the stage for a significant drilling campaign at its Yandal Gold Project in Western Australia.

Anatara Lifesciences has obtained a $400,000 loan advance from a major shareholder group against its estimated R&D tax refund for the first half of FY2025, providing crucial funding to support ongoing clinical trials and product development without immediate capital raising.

Resolute Mining has acquired AngloGold Ashanti’s Doropo and ABC gold projects in Côte d’Ivoire for US$150 million plus contingent payments, significantly boosting its resource base and positioning for production growth beyond 500,000 ounces annually by 2030.

AdAlta Limited has made significant progress in its 'East to West' cellular immunotherapy strategy by executing three CAR-T term sheets and completing technical due diligence, while implementing cost-cutting measures and seeking new capital amid a tough financing environment.